A practical evaluation of compounded semaglutide and tirzepatide through virtual health platforms — pricing structures, regulatory status, and what separates a legitimate provider from a checkout page.
Compounded GLP-1 medications have become one of the most talked-about segments of telehealth in 2026. As brand-name Ozempic and Wegovy remain expensive and intermittently supply-constrained, a growing number of telehealth platforms have stepped in to offer compounded versions of semaglutide and tirzepatide at substantially lower prices.
But the regulatory ground beneath this market is shifting constantly. Here is what you need to know about compounded GLP-1s through telehealth — the pricing, the legal framework, the risks, and which providers are worth evaluating.
Compounding is the practice of a licensed pharmacy creating a customized medication for an individual patient. Under Section 503A of the Federal Food, Drug, and Cosmetic Act, compounding pharmacies can prepare medications that are commercially available if certain conditions are met — typically a valid prescription and patient-specific preparation.
Section 503B outsourcing facilities operate under stricter FDA oversight and can produce compounded medications in larger batches without individual prescriptions. Both models are active in the GLP-1 space, and the distinction matters because 503B facilities generally offer more consistent quality controls.
Pricing varies dramatically across platforms. Some charge a flat monthly fee that includes the medication, consultation, and shipping. Others separate provider fees from pharmacy costs. Here is what we have verified across active platforms as of May 9, 2026:
The lowest price is not always the best indicator of value. What matters equally is prescriber access, dose titration support, and what happens if you experience side effects.
Compounded semaglutide and tirzepatide through a 503B-partnered pharmacy network.
From $179/mo (semaglutide) · $209/mo (tirzepatide)
Paid link · Affiliate disclosure
⚕️ Compounded medications are not FDA-approved. They are prepared by state-licensed pharmacies under Section 503A or 503B of the Federal Food, Drug, and Cosmetic Act.
Dedicated GLP-1 program with clinical monitoring and dose titration.
Plans from $130/mo (semaglutide)
Paid link · Affiliate disclosure
⚕️ Compounded medications are not FDA-approved. They are prepared by state-licensed pharmacies under Section 503A or 503B of the Federal Food, Drug, and Cosmetic Act.
Personalized weight loss protocol with ongoing provider check-ins.
Monthly plans available — pricing on intake
Paid link · Affiliate disclosure
⚕️ Compounded medications are not FDA-approved. They are prepared by state-licensed pharmacies under Section 503A or 503B of the Federal Food, Drug, and Cosmetic Act.
The legality of compounded GLP-1s is not a simple yes-or-no question. The FDA's position is that compounding is permissible when a drug is in shortage or when a clinician prescribes a meaningfully different formulation (such as a different strength or combination). The agency has taken enforcement actions against some compounders it alleges are producing essentially copies of commercially available products.
Several industry groups and compounding pharmacies have challenged the FDA in federal court, and some rulings have been favorable to compounders. As of mid-2026, compounded GLP-1s remain widely available through telehealth, but the regulatory trajectory suggests increased scrutiny rather than less.
If you are considering a compounded GLP-1 through telehealth, the most important factors are not always the ones platforms advertise. Evaluate these:
Compounded GLP-1s through telehealth offer a genuinely lower-cost pathway to medications that are otherwise unaffordable for many patients. The trade-off is regulatory uncertainty and variable quality across providers. The platforms that survive the coming regulatory shifts will be the ones with legitimate pharmacy partnerships, transparent pricing, and real clinical support — not just a checkout page with a questionnaire.
Affiliate Disclosure: Virtual Health Visits earns commissions when readers sign up through certain links. This does not influence our coverage, rankings, or editorial independence. We review providers with and without affiliate programs equally.
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider before starting any medication or treatment program.